Melsmon Injection is an in-placenta injection used by Melsmon Japan for over 50 years after the Japanese Welfare Ministry approved its use in 1956. Melsmon Korea Corp. imports the original end products manufactured in Japan. No profound side effect has been reported during its service in the past 50 years in Japan.
The placenta is an organ which weighs 500g, has a diameter of 15~20 cm, and a thickness of 2~3 cm located at the connecting point of the amnion, which wraps the fetus during pregnancy and the uterus. It contains dozens of amino acids, including essential amino acids and diverse, active peptides, vitamins, sugars, hexane, minerals, and enzymes, at the centre of pharmacologic activity.